- Home
- CNMD
CNMD
CONMED Corporation
as 05-20-2024 2:31pm EST
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.
| Founded: | 1970 | Country: | United States |
| Employees: | N/A | City: | LARGO |
| Market Cap: | 2.1B | IPO Year: | 1987 |
| Target Price: | $106.63 | AVG Volume (30 days): | 531.3K |
| Analyst Decision: | Buy | Number of Analysts: | 8 |
| Dividend Yield: | 1.07% | Dividend Payout Frequency: | Quarterly |
| EPS: | 2.61 | EPS Growth: | N/A |
| 52 Week Low/High: | $61.05 - $138.47 | Next Earning Date: | 04-24-2024 |
| Revenue: | $1,261,548,000 | Revenue Growth: | 14.83% |
| Revenue Growth (this year): | 10.63% | Revenue Growth (next year): | 8.57% |
Share on Social Networks:
Stock Insider Trading Activity of CONMED Corporation (CNMD)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Beyer Pat | CNMD | Chief Operating Officer | Apr 30 '24 | Buy | $68.30 | 3,000 | $204,900.00 | 10,807 | SEC Form 4 |
| Peters Stanley W III | CNMD | President AS and AET | Dec 4 '23 | Sell | $109.93 | 2,300 | $252,833.48 | 63 | SEC Form 4 |
Latest CONMED Corporation News
CNMD Breaking Stock News: Dive into CNMD Ticker-Specific Updates for Smart Investing
Insider Monkey
9 days ago
10 Worst-Performing Stocks Insiders are Buying in 2024
GuruFocus.com
18 days ago
Insider Buying Alert: COO Pat Beyer Acquires Shares of Conmed Corp (CNMD)
Business Wire
19 days ago
CONMED Corporation to Present at the BofA Securities Healthcare Conference
Insider Monkey
24 days ago
CONMED Corporation (NYSE:CNMD) Q1 2024 Earnings Call Transcript
Simply Wall St.
24 days ago
CONMED First Quarter 2024 Earnings: Beats Expectations
Zacks
25 days ago
CONMED (CNMD) Q1 Earnings & Revenues Surpass Estimates
MT Newswires
25 days ago
Wells Fargo Adjusts Price Target on CONMED to $77 From $98, Maintains Equalweight Rating
GuruFocus.com
a month ago